| 132699 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Forensic Blood Toxicology Scheme - (QUARTZ)
Forensic Blood Toxicology Scheme - (QUARTZ)
|
2018-01-23 |
|
|
| Tested property |
(Samples contain analytes which are pre-defined by our Advisory Group and the request of participants) |
|
| 1176653 |
United Kingdom |
Weqas
Weqas
|
Viscoelastic Haemostasis
[Viscoelastic Haemostasis]
Viscoelastic Haemostasis
[Viscoelastic Haemostasis]
|
2024-05-22 |
|
|
| Remarks |
(anonymised results. This allows for a larger peer group assessment of the results in this highly specialised) (field.
Key Features:
- Working in collaboration with ECAT.
- Large peer group assessment) |
|
| 1404083 |
Argentina |
PT SOUTH QUALITY SAS
PT SOUTH QUALITY SAS
|
Personal Protective Equipment (PPE)
Personal Protective Equipment (PPE)
|
2025-08-12 |
|
|
| Testing fields |
(Environmental conditions) |
|
| 1144039 |
United Kingdom |
Weqas
Weqas
|
POCT Respiratory Virus
[POCT Respiratory Virus]
POCT Respiratory Virus
[POCT Respiratory Virus]
|
2024-10-01 |
|
|
| Remarks |
((RSV). Platforms tend to be based on nucleic acid amplification technologies (NAAT), which generally) |
|
| 834713 |
Tanzania |
Pharmaceutical Research and Development Lab, MUHAS
Pharmaceutical Research and Development Lab, MUHAS
|
Assay and Dissolution testing for Ciprofloxacin Tablets
[Assay and Dissolution testing for Ciprofloxacin Tablets]
Assay and Dissolution testing for Ciprofloxacin Tablets
[Assay and Dissolution testing for Ciprofloxacin Tablets]
|
2021-03-09 |
|
|
| Remarks |
(-established pharmaceutical technology laboratory in which pharmaceutical samples with desired different) |
|
| 154019 |
Germany |
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
|
BOARD / PAPER
[PAPIER und KARTON]
BOARD / PAPER
[PAPIER und KARTON]
|
2025-11-03 |
|
|
| Remarks |
(A lot of microorganisms are able to form spores as dormant state to survive poor environmental) |
|
| 138891 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 2 - Markers of cardiac damage & hs-CRP
ESEAP: Greek EQA Scheme. Part 2 - Markers of cardiac damage & hs-CRP
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 138902 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 3 - Thyroid hormones
ESEAP: Greek EQA Scheme. Part 3 - Thyroid hormones
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 138914 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 4 - Therapeutic drug monitoring
ESEAP: Greek EQA Scheme. Part 4 - Therapeutic drug monitoring
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275550 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 6 - Reproduction Hormones and Anemia Markers
ESEAP: Greek EQA Scheme. Part 6 - Reproduction Hormones and Anemia Markers
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275579 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 7 - Tumor Markers
ESEAP: Greek EQA Scheme. Part 7 - Tumor Markers
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275600 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 8 - Coagulation Factors
ESEAP: Greek EQA Scheme. Part 8 - Coagulation Factors
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275781 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 9- Specific Proteins
ESEAP: Greek EQA Scheme. Part 9- Specific Proteins
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275810 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 10- Immunology Tests
ESEAP: Greek EQA Scheme. Part 10- Immunology Tests
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 275845 |
Greece |
ESEAP
ESEAP
|
ESEAP: Greek EQA Scheme. Part 11- Serology Tests (TORCH)
ESEAP: Greek EQA Scheme. Part 11- Serology Tests (TORCH)
|
2023-05-04 |
|
|
| Remarks |
(the grouping of methods and instruments (analyzers), the enhancement of the statistical evaluation of the results.) |
|
| 664050 |
Czechia |
SEKK
SEKK
|
VIB – General Immunohistochemistry - Staining
[VIB – Všeobecná imunohistochemie - barvení]
VIB – General Immunohistochemistry - Staining
[VIB – Všeobecná imunohistochemie - barvení]
|
2020-03-26 |
|
|
| Remarks |
(expert group meeting.
Complete EQA Plan is available here: http://www.sekk.cz/eqa/EQA_1.htm) |
|
| 664026 |
Czechia |
SEKK
SEKK
|
HCB – Histological and Cytological Staining
[HCB – Histologické a cytologické barvení]
HCB – Histological and Cytological Staining
[HCB – Histologické a cytologické barvení]
|
2020-03-26 |
|
|
| Remarks |
(expert group meeting.
Complete EQA Plan is available here: http://www.sekk.cz/eqa/EQA_1.htm) |
|
| 182805 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Drug screening in urine
[Drogenscreening]
Drug screening in urine
[Drogenscreening]
|
2021-02-18 |
|
|
| Remarks |
(Per survey the samples do contain selected drugs from a lot of substances of a drug group.
The) |
|
| 824020 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
Allergology
[Allergologie]
Allergology
[Allergologie]
|
2021-02-18 |
|
|
| Remarks |
(IgE-antibodies we will supply changing groups of antibodies investigation. It is also possible to) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2022-05-04 |
|
|
| Remarks |
(the scheme is supported by an Advisory Group consisting of experts in the field of Clinical) |
|
